In the West, the predominant immunophenotype observed in ALL was B-ALL, accounting for 60-80% of total cases, whereas T-ALL comprised only of 15-20%.[ 6 ] In India also, studies reported from Tata Memorial Hospital, Mumbai, All India Institute of Medical Sciences, New Delhi and Cancer Institute, Chennai revealed a declining trend of T-ALL accompanied by an increasing trend in B-ALL among children.[ 7 , 8 , 9 ] Thus most of these studies have focused predominantly on B-ALL.
← all excerpts
Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India.
1
—
—